Warr Acres Doctor Pleads Guilty to Drug and Identity-Theft Charges

OKLAHOMA CITY – DAVID QUY, 62, an Oklahoma City resident who practiced medicine in Warr Acres, has pleaded guilty to obtaining prescription opioids by fraud and also to identity theft, announced U.S. Attorney Timothy J. Downing.

According to an indictment returned by a federal grand jury on September 17, 2019, Quy practiced as a Doctor of Osteopathy at Family Medicine Center, 5500 N.W. Expressway, in Warr Acres from as early as 2014 until May 2019.  He was charged with writing prescriptions for certain of his employees and then directing those employees to fill the prescriptions and bring the pills back to him.  On May 14, 2019, the Oklahoma Bureau of Narcotics and Dangerous Drugs issued an emergency suspension of Quy’s license to prescribe controlled substances.

Quy pleaded guilty today before U.S. District Judge Charles B. Goodwin to two counts: obtaining a controlled substance by fraud and using another person’s identity without lawful authority to commit the offense of dispensing controlled substances illegally.  The first count charges that on March 20, 2019, he obtained 40 tablets of the opioid Oxycodone by authorizing a prescription in the name of one of his employees and causing that employee to fill the prescription and return the tablets to him.  The second count charges him with using the employee’s identity on April 4, 2019, to obtain additional Oxycodone for his own use.

At sentencing, Quy faces on the first count up to four years in prison, one year of supervised release, and a fine of up to $250,000.  On the second count, he could be imprisoned up to five years, serve an additional three years on supervised release, and be subject to a $250,000 fine.  Quy has agreed in a plea agreement to pay a fine of $50,000.  He has also agreed to surrender any license related to the provision of health care and not to apply for any health-care license for two years after sentencing.  Sentencing will take place in approximately ninety days.

This case is the result of an investigation by the Oklahoma Bureau of Narcotics and Dangerous Drugs, with assistance from the Drug Enforcement Administration.  Assistant U.S. Attorney Scott E. Williams is prosecuting the case.

Reference is made to public filings for more information.